Literature DB >> 21307333

Membrane-tethered peptides patterned after the TRP domain (TRPducins) selectively inhibit TRPV1 channel activity.

Pierluigi Valente1, Asia Fernández-Carvajal, María Camprubí-Robles, Ana Gomis, Susana Quirce, Félix Viana, Gregorio Fernández-Ballester, José M González-Ros, Carlos Belmonte, Rosa Planells-Cases, Antonio Ferrer-Montiel.   

Abstract

The transient receptor potential vanilloid 1 (TRPV1) channel is a thermosensory receptor implicated in diverse physiological and pathological processes. The TRP domain, a highly conserved region in the C terminus adjacent to the internal channel gate, is critical for subunit tetramerization and channel gating. Here, we show that cell-penetrating, membrane-anchored peptides patterned after this protein domain are moderate and selective TRPV1 antagonists both in vitro and in vivo, blocking receptor activity in intact rat primary sensory neurons and their peripheral axons with mean decline time of 30 min. The most potent lipopeptide, TRP-p5, blocked all modes of TRPV1 gating with micromolar efficacy (IC(50)<10 μM), without significantly affecting other thermoTRP channels. In contrast, its retrosequence or the corresponding sequences of other TRPV channels did not alter TRPV1 channel activity (IC(50)>100 μM). TRP-p5 did not affect the capsaicin sensitivity of the vanilloid receptor. Our data suggest that TRP-p5 interferes with protein-protein interactions at the level of the TRP domain that are essential for the "conformational" change that leads to gate opening. Therefore, these palmitoylated peptides, which we termed TRPducins, are noncompetitive, voltage-independent, sequence-specific TRPV1 blockers. Our findings indicate that TRPducin-like peptides may embody a novel molecular strategy that can be exploited to generate a selective pharmacological arsenal for the TRP superfamily of ion channels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307333     DOI: 10.1096/fj.10-174433

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  The Integrity of the TRP Domain Is Pivotal for Correct TRPV1 Channel Gating.

Authors:  Lucia Gregorio-Teruel; Pierluigi Valente; Beiying Liu; Gregorio Fernández-Ballester; Feng Qin; Antonio Ferrer-Montiel
Journal:  Biophys J       Date:  2015-08-04       Impact factor: 4.033

Review 2.  Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development.

Authors:  Katie O'Callaghan; Athan Kuliopulos; Lidija Covic
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

3.  Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.

Authors:  Ping Zhang; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2015

4.  Intracellular proton-mediated activation of TRPV3 channels accounts for the exfoliation effect of α-hydroxyl acids on keratinocytes.

Authors:  Xu Cao; Fan Yang; Jie Zheng; Kewei Wang
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

5.  Targeting the transient receptor potential vanilloid type 1 (TRPV1) assembly domain attenuates inflammation-induced hypersensitivity.

Authors:  Robyn Flynn; Kevin Chapman; Mircea Iftinca; Reem Aboushousha; Diego Varela; Christophe Altier
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

6.  Transient receptor potential vanilloid 1 inhibitors block laparotomy- and opioid-induced infarct size reduction in rats.

Authors:  Helen M Heymann; Yun Wu; Yao Lu; Nir Qvit; Garrett J Gross; Eric R Gross
Journal:  Br J Pharmacol       Date:  2017-11-21       Impact factor: 8.739

7.  The region adjacent to the C-end of the inner gate in transient receptor potential melastatin 8 (TRPM8) channels plays a central role in allosteric channel activation.

Authors:  Francisco José Taberner; Ainara López-Córdoba; Gregorio Fernández-Ballester; Yuri Korchev; Antonio Ferrer-Montiel
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

8.  Mutation of I696 and W697 in the TRP box of vanilloid receptor subtype I modulates allosteric channel activation.

Authors:  Lucia Gregorio-Teruel; Pierluigi Valente; José Manuel González-Ros; Gregorio Fernández-Ballester; Antonio Ferrer-Montiel
Journal:  J Gen Physiol       Date:  2014-03       Impact factor: 4.086

9.  New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.

Authors:  Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Isabel Devesa; José Manuel González-Ros; Antonio Ferrer-Montiel
Journal:  Pharmaceuticals (Basel)       Date:  2011-12-27

10.  Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.

Authors:  Youn Sook Lee; Jin Seok Park; Su Myung Jung; Sang-Doo Kim; Jun Hwan Kim; Jae Young Lee; Kyeong Cheon Jung; Mizuko Mamura; Sangho Lee; Seong-Jin Kim; Yoe-Sik Bae; Seok Hee Park
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.